Influenza virus therapy (Achelois BioPharma)

N/A

Report date: 2025/05/07 16:33:41

Base Information

Drug NameInfluenza virus therapy (Achelois BioPharma)
Drug Alias NameAb-MVP
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAchelois BioPharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAchelois BioPharma Inc
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A